In another longitudinal follow-up study with 20 newly diagnosed patients with PD, DAT binding in the putamen decreased by 4.2% per year; however, there was no significant change in the caudate nucleus during 30 months of follow-up [73]. This evidence concerns the gene SLC6A3 and Parkinson disease.